MRK  Merck & Company Inc.

Exchange

NYSE

Sector

Consumer Durables

Industry

Major Pharmaceuticals

Market Cap.

162.82B

Vuru Grade

54.36/100

Current Price

$58.82
+0.03 (+0.05%)

Growth Price

$54.41
Overvalued by 7.49%

Stability Price

$20.51
Overvalued by 65.13%

Company Metrics

  • P/E 36.06
  • P/S 4.13
  • P/B 3.72
  • EPS 1.63
  • Cash ROIC 12.97%
  • Cash Ratio 0.70
  • Dividend 1.84 / 3.13%
  • Avg. Vol. 8.83M
  • Shares 2.77B
  • Market Cap. 162.82B

Company Description

Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company's Pharmaceutical segment provides human health pharmaceutical products, such as therapeutic and preventive agents for the treatment of human disorders in the areas of bone, respiratory, immunology, dermatology, cardiovascular, ... more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

Merck & Co., Inc. (NYSE:MRK) Analyst Research Summary
Zergwatch - Jul 22, 2016
Merck & Co., Inc. (NYSE:MRK) stock is currently trading at about $58.79 and lots of rating firms seem to have a target price set on the stock.
Envestnet Asset Management Inc. Raises Position in Merck & Co. (MRK) - The Cerbat Gem
Latest Merck & Co. Inc. (NYSE:MRK) Target Price Suggests Stock Is Worth $61.7 ... - Review Fortune
Merck & Co., Inc. (NYSE:MRK) Embattled By Over 400 Pay Discrimination Claims
Market Exclusive - Jul 22, 2016
Feinstein Doyle Payne & Kravec LLC and Sanford Heisler, LLP have revealed that more than 400 women had already reached out with discrimination claims relating to the $250 million women discrimination class action lawsuit against Merck & Co., Inc.
How Merck & Co., Inc. Ranks As a Top Analyst Pick (MRK)
Investorplace.com - Jul 20, 2016
A study of analyst recommendations at the major brokerages shows that Merck & Co., Inc. is the #15 broker pick, on average, out of the 30 stocks making up the Dow Jones Industrial Average, according to ETF Channel.
Stock to Track: Merck & Co. Inc. (NYSE:MRK)
News Oracle - Jul 22, 2016
The Company fell -0.09% and finished at $58.74. The daily volume was measured at 4.96 million shares. The 52-week high of the share price is $60.07 and the 52-week low is $45.69.
Better Buy: Merck & Co. Inc. vs. AbbVie
Motley Fool - Jun 27, 2016
Among pharmaceutical companies, Merck & Co. (NYSE:MRK) and AbbVie (NYSE:ABBV) have been two of the most successful and profitable over the long run, and their share prices have posted impressive long-term returns for shareholders.
Stock buzz: Merck & Co., Inc. (NYSE:MRK) - Zergwatch
BMO Capital Markets Reiterates Outperform Rating for Merck & Co., Inc. (MRK) - Community Financial News
Huntington Bancshares (NASDAQ:HBAN) & Merck & Co., Inc. (NYSE:MRK) Stock's Buzzers
Money News (press release) - Jul 22, 2016
On Thursday, Shares of Huntington Bancshares Incorporated (NASDAQ:HBAN) lost -0.87% to $9.16. The share price is trading in a range of $9.11 - $9.34.
Merck & Co., Inc. (MRK) and OpGen Inc (OPGN) Are Quietly Changing The ...
Insider Monkey (blog) - Jul 19, 2016
Merck & Co., Inc. (NYSE:MRK) is one exception. Through its venture capital arm, Merck is funding the development of what looks set to become a big part of the solution to the antibiotic resistance problem.
Merck & Co., Inc. (NYSE:MRK) KGaA To Build A New Life Science Hub Worthy $115 ...
Market Exclusive - Jul 20, 2016
Merck & Co., Inc. (NYSE:MRK) KGaA has announced its plan to construct a new major life science hub in Burlington, Massachusetts.
Market Exclusive's Inside the FDA: This Week Bezlotoxumab from Merck & Co ...
Insider Monkey (blog) - Jul 22, 2016
On July 23, the Food and Drug Administration will make its decision on bezlotoxumab, brand name Zinplava, a Merck & Co.
Merck Provides Regulatory Update on Biologics Licensing Application for ... - Business Wire (press release)
Option Market: Merck & Co. Inc Risk Hits An Extreme Low
CML News - Jul 18, 2016
This is a proprietary risk rating for the next 30-days built by Capital Market Laboratories (CMLviz) based on a large number of interactions of data points, many of which come directly from the option market for Merck & Co. Inc (NYSE:MRK) . Risk as ...